Labiotech.eu

News and Trends 7 Jul 2020

Hansa Biopharma Gets up to €350M to Make Gene Therapy Work in Resistant Patients

Hansa Biopharma has granted an exclusive license to Sarepta Therapeutics for developing and promoting a pretreatment aimed to make a gene therapy to treat muscular dystrophy available to people that are naturally resistant to the treatment. Gene therapy can be used to treat genetic conditions by delivering a healthy copy of the faulty gene using […]

July 7, 2020 - 2 minutesmins - By Antara Mazumdar

News and Trends 7 Jul 2020

Dutch-Swiss Team to Fight Milk Fraud with Onsite DNA Testing

Microfluidics company DigiBio and food security specialist SwissDeCode have joined forces to automate onsite milk testing and track down fraudulent adulterants such as vegetable ingredients or milk from different species. Milk is the second most likely food at risk of adulteration after olive oil. This fraudulent practice can mislead consumers at best, and cause major […]

July 7, 2020 - 3 minutesmins - By Manuela Callari

In Depth 6 Jul 2020

How Immuno-Oncology Contributes to the Fight Against Covid-19

As the Covid-19 pandemic sweeps the world, cancer research is proving a valuable resource for developing new treatments for infectious diseases by harnessing the power of the immune system. Despite the growing number of viral outbreaks of different sizes and severity we have observed in the past years, the infectious disease market is far behind […]

July 6, 2020 - 7 minutesmins - By Maya Chergova

News and Trends 3 Jul 2020

CRISPR Therapeutics Announces Huge €400M Public Fundraise

The Swiss firm CRISPR Therapeutics has priced a public offering on the Nasdaq Global Market at around €400M, which it will use to develop therapies based on the gene editing tool CRISPR/Cas9 for genetic disorders and cancer. This fundraise is the second-highest global share offering from a European biotech so far this year after the […]

July 3, 2020 - 2 minutesmins - By Laura Cowen

News and Trends 3 Jul 2020

Pfizer-BioNTech Covid-19 Vaccine Shows Phase I Promise

A vaccine made out of messenger RNA (mRNA), developed by the US pharmaceutical giant Pfizer and its German partner BioNTech, has produced antibodies against the Covid-19 pathogen in healthy volunteers. The results come from an interim analysis of an ongoing phase I clinical trial in 45 participants. So far, all test subjects who received two […]

July 3, 2020 - 3 minutesmins - By Victor Kotsev

News and Trends 2 Jul 2020

Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy

UK biotech Freeline Therapeutics has extended its Series C round to take its gene therapy for hemophilia B to a pivotal trial, while hinting at the possibility of an IPO in the US later this year. This final closing adds an additional €70M to a €36M Series C investment by London-based VC Syncona in December […]

July 2, 2020 - 3 minutesmins - By Helen Albert

Reports 2 Jul 2020

Guidelines for Biotechs: Managing Risks in Biological Drug Development

Navigating the complexity of the industry can be highly challenging for early-stage biotechs focusing on biological drug development. Once they have a robust strategy in place and have chosen a suitable partner, biotechs face other hurdles in upstream process development, manufacturing, IND filing, and regulatory processes. Discover how to address challenges and manage risks throughout […]

July 2, 2020 - 2 minutesmins - By Larissa Warneck-Silvestrin

sonoran desert toad psychedelic beckley psytech

News and Trends 1 Jul 2020

UK Startup Bags €3M to Develop Psychedelic Medicines for Mental Health

A €3.3M (£3M) Series A round raised by the Oxford-based biomedicine company Beckley Psytech will allow the company to study the use of a psychedelic compound for the treatment of mental health disorders and neuropsychiatric disease. The investors include the UK VC firms Mediqventures and Jamjar Investments, which was set up by Richard Reed, co-founder […]

July 1, 2020 - 3 minutesmins - By Kostas Vavitsas

News and Trends 1 Jul 2020

Swiss Regenerative Medicine Biotech Closes €19M Series B

The regenerative medicine startup Cutiss has raised €18.8M (CHF 20M) to commercialize its personalized skin graft treatment for burn patients in Switzerland and the European Union around 2022. This is the final closing of a Series B round announced earlier this month. The lead investor in the oversubscribed round was the Swiss firm Gisev Family […]

July 1, 2020 - 3 minutesmins - By David Wilson

Expert Advice 1 Jul 2020

Why Biotech Must Change its Cleaning and Disinfection Strategy

Many biotech companies deploy strong chemicals to clean and disinfect their equipment. However, if handled in the wrong way, this can lead to dangerous problems such as antibiotic resistance. As the EU prepares to release new guidelines on good manufacturing practices, it’s time to revise how cleaning is approached in the industry. To effectively control […]

July 1, 2020 - 10 minutesmins - By Melanie Maria Obermeier

News and Trends 30 Jun 2020

Kymab Wins UK Supreme Court Antibody Battle Against Regeneron

The UK Supreme Court has supported an appeal by British biotech Kymab to revoke antibody drug patents held by US giant Regeneron, a decision that could make it harder for big patent holders to clamp down on small innovators in the biotech industry. Kymab and Regeneron have been battling it out in the UK since […]

June 30, 2020 - 4 minutesmins - By Anita Chakraverty

News and Trends 29 Jun 2020

Enterome Secures €46M to Take Microbiome Therapies to Clinical Trials

French microbiome biotech Enterome has raised €46.3M in Series E funding to progress its cancer and inflammatory bowel disease therapies to phase I trials in a few weeks. Two new investors to Enterome — SymBiosis, a US-based investor, and the Japanese big pharma Takeda — took part in the fundraise in addition to existing investors […]

June 29, 2020 - 3 minutesmins - By Helen Albert

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Hansa Biopharma Gets up to €350M to Make Gene Therapy Work in Resistant Patients

Dutch-Swiss Team to Fight Milk Fraud with Onsite DNA Testing

How Immuno-Oncology Contributes to the Fight Against Covid-19

CRISPR Therapeutics Announces Huge €400M Public Fundraise

Pfizer-BioNTech Covid-19 Vaccine Shows Phase I Promise

Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy

Guidelines for Biotechs: Managing Risks in Biological Drug Development

UK Startup Bags €3M to Develop Psychedelic Medicines for Mental Health

Swiss Regenerative Medicine Biotech Closes €19M Series B

Why Biotech Must Change its Cleaning and Disinfection Strategy

Kymab Wins UK Supreme Court Antibody Battle Against Regeneron

Enterome Secures €46M to Take Microbiome Therapies to Clinical Trials

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!